Boston University & Med-IQ: Live ECHO® Program
Empowering the Care Team: Practical Strategies for Implementing BCMA Therapies in Relapsed Refractory Multiple Myeloma
Through interactive cases and expert-led discussions, our ECHO® sessions and Community of Practice calls help community oncology teams:
- Characterize the safety and efficacy of BCMA-directed bsAbs for the treatment of MM
- Appropriately incorporate BCMA-directed bsAbs into cases of patients with MM that are representative of clinical practice
- Establish and follow workflows and lines of communication for monitoring and managing BCMA bsAb treatment-related adverse events
- Summarize the importance and benefits of CoPs to providing coordinated, multidisciplinary, and interprofessional care for patients with MM receiving BCMA-directed bsAbs
Cost: Free
View Offer chevron_rightDetails
Empowering the Care Team: Practical Strategies for Implementing BCMA Therapies in Relapsed Refractory Multiple Myeloma
Through interactive cases and expert-led discussions, our ECHO® sessions and Community of Practice calls help community oncology teams:
- Characterize the safety and efficacy of BCMA-directed bsAbs for the treatment of MM
- Appropriately incorporate BCMA-directed bsAbs into cases of patients with MM that are representative of clinical practice
- Establish and follow workflows and lines of communication for monitoring and managing BCMA bsAb treatment-related adverse events
- Summarize the importance and benefits of CoPs to providing coordinated, multidisciplinary, and interprofessional care for patients with MM receiving BCMA-directed bsAbs
Topics Covered
Sessions in this Series
- BCMA-Directed Bispecific Antibodies in Multiple Myeloma: Mechanisms of Action, Clinical Efficacy, and Emerging Therapeutics
- Prevention, Monitoring, and Management of Adverse Events Associated With BCMA-Directed Bispecific Antibodies in Multiple Myeloma
- BCMA-Directed Bispecific Antibodies in Multiple Myeloma: Bridging Academic and Community Practice
- Community of Practice (COP) Session #1
- Quality of Life and Patient Experience With BCMA-Directed Therapies in Multiple MyelomaReal World Use of BCMA-Directed Bispecific Antibodies for Multiple Myeloma: A Panel Discussion on Experiences, Challenges, and Solutions in Community Settings
- Integrating BCMA-Directed Bispecific Antibodies Into the Treatment Algorithm for Multiple Myeloma
- Community of Practice (COP) Session #2
- BCMA-Directed BsAbs in Multiple Myeloma: Overcoming Barriers to Care
- Community of Practice (COP) Session #3
Target Audience
This activity is intended primarily for oncologists and other healthcare professionals responsible for the care and treatment of patients with RRMM.
Additional credit info
This activity is developed as a joint collaboration among Boston University Chobanian & Avedisian School of Medicine, Med-IQ, the AAPA, the Association of PAs in Oncology (APAO), and HealthTree Foundation.
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Accreditation
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Internal Medicine Maintenance of Certification (MOC) Part 2 Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
By participating and claiming credit, you agree to BU sharing your information with ACCME PARS the data conduit to the ABIM.
Nurse Accreditation
Nursing Contact Hours: 1.0, of which 1.0 is eligible for pharmacology credit.
Pharmacist Accreditation
This activity is approved for 1.0 CPE credit.
Physician Associate Accreditation
Boston University Chobanian & Avedisian School of Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.